Creative Touch Permanent Makeup and Aesthetics

RF microneedling (MNRF) combines the wound healing cascade of standard microneedling with a second, independent mechanism: controlled delivery of bipolar radiofrequency energy at insulated needle tips. The thermal component generates radiofrequency thermal zones (RFTZs) in the dermis, triggering HSP47-mediated collagen synthesis and HSP70-mediated NF-κB suppression – a pathway that simultaneously drives collagen production and reduces MMP-driven degradation. A 2025 Seoul National University split-face RCT demonstrated a mechanism that distinguishes MNRF from all other collagen stimulation treatments in the portfolio: RF thermal energy induces apoptosis of senescent fibroblasts and their replacement by freshly proliferating non-senescent fibroblasts, with the degree of senescent fibroblast clearance correlating directly with improvements in collagen density. The treatment also produces measurable increases in tropoelastin and fibrillin – the elastic fibre scaffolding components – making it the primary tool for skin laxity and elastic fibre fragmentation as well as structural collagen restoration. MNRF is the most structurally complete treatment in the portfolio for clients where ageing-environment remodelling, rather than environment preparation alone, is the clinical priority.

RF microneedling (MNRF) is a minimally invasive procedure that combines fine-needle percutaneous micro-injury with the controlled delivery of bipolar radiofrequency energy. It is architecturally and mechanistically distinct from standard microneedling: where standard microneedling initiates healing through physical tissue disruption alone, MNRF adds a thermal energy component that generates independent biological effects in the dermis – effects that include senescent fibroblast clearance, heat shock protein-mediated collagen chaperone activity, and elastic fibre precursor upregulation – none of which standard needling produces to a clinically significant degree. The insulated needle design is central to how the treatment delivers these effects: the shaft is electrically non-conducting, so RF energy is released only at the exposed needle tips in the dermis, preserving the overlying epidermis from thermal spread. This architecture is what allows precise reticular dermal targeting whilst maintaining a surface recovery profile significantly shorter than ablative laser alternatives. ^[1]

The Dual Mechanism

Component 1 – Wound healing cascade: Needle penetration creates controlled micro-injuries that initiate the same three-phase wound healing response as standard microneedling – inflammation, proliferation, and remodelling – releasing TGF-β, PDGF, and VEGF, recruiting fibroblasts, stimulating Type I and III collagen synthesis, and driving fibronectin matrix formation. This component of MNRF is mechanistically identical to standard microneedling and produces the same basket-weave collagen architecture through TGF-β3 isoform predominance. ^[4]

Component 2 – RF thermal mechanism: Bipolar RF energy delivered at needle tips generates resistive heating in the surrounding dermal tissue, creating radiofrequency thermal zones (RFTZs) of precisely calibrated thermal injury. This thermal component produces a cascade that is entirely independent of the wound healing route: immediate collagen denaturation and contraction; HSP47 and HSP70 upregulation; tropoelastin and fibrillin induction; and, as 2025 evidence now confirms, apoptosis of senescent dermal fibroblasts followed by their replacement by newly proliferating non-senescent fibroblasts. ^{[1] [2]} These two components operate simultaneously, but they activate different cell populations, different molecular pathways, and produce different structural outcomes. That is why MNRF is not simply an enhanced version of microneedling – it is a treatment that contains microneedling as one of its two mechanisms.

The Senescent Fibroblast Mechanism

The most clinically significant mechanistic distinction MNRF holds over every other treatment in the portfolio is its selective effect on fibroblast senescence – a finding confirmed in a 2025 Seoul National University split-face RCT that, for the first time, directly compared MNRF to standard microneedling on the same patients with biopsy analysis. ^[2]

Senescent fibroblasts – cells that have exited the cell cycle due to cumulative UV damage, oxidative stress, or telomere shortening – do not produce collagen. They secrete instead a toxic inflammatory mix collectively termed the senescence-associated secretory phenotype (SASP): pro-inflammatory cytokines, MMPs, and other factors that actively degrade the ECM whilst suppressing collagen synthesis in neighbouring cells. The accumulation of senescent fibroblasts in aged and photodamaged skin is one of the central reasons why other collagen-stimulating treatments – including standard microneedling – produce less pronounced results in older or significantly photodamaged clients than the mechanism alone would predict. You are applying the stimulus to a fibroblast population that is, in part, constitutively non-functional and actively hostile to collagen preservation.

RF thermal energy addresses this through a mechanism that no topical, injectable, or standard needling treatment can replicate: cleaved caspase-3 and TUNEL evidence confirms that thermal energy at needle tips induces apoptosis of dermal fibroblasts non-specifically – affecting both senescent and non-senescent cells in the RFTZs. The body then repopulates these zones through proliferation. Crucially, the cells that proliferate to replace the apoptosis-cleared population are predominantly non-senescent: p16^INK4A^-negative, HSP47-positive, synthetically active fibroblasts. ^[2] The 2025 RCT confirmed that the proportion of senescent fibroblasts decreased significantly on the MNRF-treated side, the absolute count of non-senescent, collagen-producing fibroblasts increased simultaneously, and – critically – the degree of this senescent fibroblast clearance correlated directly with improvements in collagen density and hydration. This is not a peripheral observation; it establishes the clearance of senescent fibroblasts as an active mechanism of outcome, not merely a bystander effect.

Senescent Fibroblast Clearance: Why It Matters Clinically

^[2]

HSP47 and HSP70: The Two Heat Shock Pathways

The thermal component of MNRF activates two heat shock protein pathways with distinct downstream effects.

HSP47 – the collagen chaperone: HSP72 (the acute stress response protein) peaks rapidly after RF treatment and then diminishes. HSP47 – a collagen-specific chaperone protein that stabilises procollagen triple helices in the endoplasmic reticulum – increases progressively through ten weeks. ^[1] This extended HSP47 expression is responsible for the sustained collagen synthesis that follows MNRF well beyond the initial wound healing window, and the 2009 foundational bipolar RF histology study confirmed complete replacement of all RFTZs with new collagen by ten weeks post-treatment – driven by this HSP47 chaperone activity. HSP47 expression tripling with higher RF energy settings confirms that energy calibration directly scales the collagen synthesis response.

HSP70 – the NF-κB suppressor: A 2025 study examining RF irradiation in senescent facial ligaments established a distinct and clinically important second pathway. RF enhances the interaction between HSP70 and IKKγ (a component of the IκB kinase complex), reducing IκBα phosphorylation and thereby decreasing NF-κB activation in senescent fibroblasts. ^[3] NF-κB suppression via HSP70 simultaneously downregulates MMP expression and SMAD7 (an inhibitory SMAD that suppresses TGF-β signalling) in the treated tissue – creating a dermal environment that is simultaneously more synthetically active and less degradative. The clinical significance: MNRF does not simply stimulate collagen production whilst leaving the MMP-driven degradation environment intact. The HSP70-NF-κB pathway directly reduces the enzymatic degradation that would otherwise erode whatever new collagen is being produced.

Tropoelastin, Fibrillin, and the Elastic Fibre Dimension

RF microneedling is the most effective treatment in the portfolio for elastic fibre restoration – a dimension of dermal ageing that standard microneedling, polynucleotides, and skin boosters address partially or indirectly, but that MNRF addresses through a direct molecular mechanism. The foundational bipolar RF histology study confirmed marked induction of both tropoelastin and fibrillin – the two principal structural proteins of mature elastic fibres – at 28 days post-treatment, alongside procollagens I and III. ^[1] The 2025 split-face RCT confirmed a significant increase in elastin fluorescence intensity in the treated dermis at three and five months. ^[2] This is clinically relevant because skin laxity – the loss of the skin’s ability to recoil against gravity – is primarily an elastic fibre fragmentation problem rather than a pure collagen deficit. Restoring collagen density in skin with severely fragmented elastic fibres improves texture and quality but does not restore recoil. Tropoelastin and fibrillin upregulation through the thermal HSP mechanism is the route to genuine laxity correction, and it is specific to energy-based treatments.

Depth, Tissue Zone Targeting, and an Important Nuance

MNRF protocols use insulated needles at adjustable depths (typically 1.5–4mm for facial applications; up to 7mm for body) with the RF energy deposited at the tip. Standard protocols for skin quality and laxity target the mid-to-deep reticular dermis – the tissue zone where structural collagen architecture, fibrillin scaffolding, and elastic fibre networks are located. At depths of 3.5–4mm and beyond, RF energy reaches the superficial fat compartment, inducing adipocyte remodelling and contributing to the contouring and submental fat reduction effects that fall outside standard microneedling’s capability.

One nuance from the 2025 split-face RCT deserves honest acknowledgement: the study’s quantitative histological analysis found that the significant increases in collagen deposition and elastin fluorescence were measured in the papillary dermis rather than the reticular zone. ^[2] This does not contradict the reticular dermis targeting rationale – the study’s settings and the particular biopsy analysis zones used may not have captured the full reticular depth effect – but it does suggest that a binary papillary/reticular framework may be a simplification of where the measurable cellular changes actually occur. The tissue zone targeting model is a useful clinical organising principle, but it should be held as a framework rather than a rigid boundary.

Evidence Base

The histological evidence base for RF microneedling is established and meaningful. Biopsy studies across multiple controlled investigations show: collagen increase of up to 25% at three months; elastin increase of 33.3% with improved fibre organisation; dermal thickness increase of 15–20% at three months; reduced inflammatory infiltration and reduced elastin fragmentation. The 247-patient retrospective study reported a 1.4-point improvement in lower face and neck laxity on the Baker Face/Neck Classification, with 93% patient satisfaction. A 2024 Morpheus8 histological study of patients aged 40+ confirmed particularly pronounced elastogenesis stimulation in older patients – an age-dependent benefit that aligns directly with the senescent fibroblast clearance mechanism: the clients with the most accumulated senescent burden potentially benefit most from the thermal replacement pathway.